The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like Calithera Biosciences Appoints To Board Of Directors September 21, 2017 Amazon in Exploratory Talks With Mylan, Novartis About Pharma Entry November 30, 2017 FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases April 6, 2017
